A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction
Tài liệu tham khảo
Boyle, 2006, Is stem cell therapy ready for patients?, Circulation, 114, 339, 10.1161/CIRCULATIONAHA.105.590653
Abdel-Latif, 2007, Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis, Arch Intern Med, 167, 989, 10.1001/archinte.167.10.989
Schachinger, 2006, Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction, N Engl J Med, 355, 1210, 10.1056/NEJMoa060186
van der, 2008, Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results, Neth Heart J, 16, 436, 10.1007/BF03086194
Schaefer, 2006, Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial, Eur Heart J, 27, 929, 10.1093/eurheartj/ehi817
Assmus, 2007, Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD registry, Circ Res, 100, 1234, 10.1161/01.RES.0000264508.47717.6b
Schuleri, 2007, Mesenchymal stem cells for cardiac regenerative therapy, Handb Exp Pharmacol, 180, 195, 10.1007/978-3-540-68976-8_9
Chamberlain, 2007, Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing, Stem Cells, 25, 2739, 10.1634/stemcells.2007-0197
Rubio, 2005, Spontaneous human adult stem cell transformation, Cancer Res, 65, 3035, 10.1158/0008-5472.CAN-04-4194
Breitbach, 2007, Potential risks of bone marrow cell transplantation into infarcted hearts, Blood, 110, 1362, 10.1182/blood-2006-12-063412
Vulliet, 2004, Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs, Lancet, 363, 783, 10.1016/S0140-6736(04)15695-X
1985, The Thrombolysis In Myocardial Infarction (TIMI) trial, N Engl J Med, 312, 932, 10.1056/NEJM198504043121437
Gibson, 2000, Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs, Circulation, 101, 125, 10.1161/01.CIR.101.2.125
Schiller, 1989, Recommendations for quantitation of the left ventricle by two-dimensional echocardiography, J Am Soc Echocardiogr, 2, 358, 10.1016/S0894-7317(89)80014-8
Kwong, 2003, Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging, Circulation, 107, 531, 10.1161/01.CIR.0000047527.11221.29
2002, ATS statement: guidelines for the six-minute walk test, Am J Respir Crit Care Med, 166, 111, 10.1164/ajrccm.166.1.at1102
Meyer, 2006, Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial, Circulation, 113, 1287, 10.1161/CIRCULATIONAHA.105.575118
Bartunek, 2006, The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart, Eur Heart J, 27, 1338, 10.1093/eurheartj/ehi793
Dai, 2005, Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects, Circulation, 112, 214, 10.1161/CIRCULATIONAHA.104.527937
Freyman, 2006, A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction, Eur Heart J, 27, 1114, 10.1093/eurheartj/ehi818
Kraitchman, 2003, In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction, Circulation, 107, 2290, 10.1161/01.CIR.0000070931.62772.4E
Silva, 2005, Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model, Circulation, 111, 150, 10.1161/01.CIR.0000151812.86142.45
Amado, 2005, Cardiac repair with intra-myocardial injection of allogeneic mesenchymal stem cells following myocardial infarction, Proc Natl Acad Sci U S A, 102, 11474, 10.1073/pnas.0504388102
Quevedo, 2009, Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity, Proc Natl Acad Sci U S A, 106, 14022, 10.1073/pnas.0903201106
Burns, 2005, Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells, Cancer Res, 65, 3126, 10.1158/0008-5472.CAN-04-2218
Chin, 2003, 111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction, Nucl Med Commun, 24, 1149, 10.1097/00006231-200311000-00005
Ringden, 2006, Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease, Transplantation, 81, 1390, 10.1097/01.tp.0000214462.63943.14
Horwitz, 2002, Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone, Proc Natl Acad Sci U S A, 99, 8932, 10.1073/pnas.132252399
Koc, 2002, Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH), Bone Marrow Transplant, 30, 215, 10.1038/sj.bmt.1703650
Mazhari, 2007, Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche, Nat Clin Pract Cardiovasc Med, 4, S21, 10.1038/ncpcardio0770
Mirotsou, 2007, Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair, Proc Natl Acad Sci U S A, 104, 1643, 10.1073/pnas.0610024104
Anversa, 2006, Life and death of cardiac stem cells: a paradigm shift in cardiac biology, Circulation, 113, 1451, 10.1161/CIRCULATIONAHA.105.595181
Urbanek, 2006, Stem cell niches in the adult mouse heart, Proc Natl Acad Sci U S A, 103, 9226, 10.1073/pnas.0600635103